Search for: "ACTAVIS"
Results 901 - 920
of 1,010
Sort by Relevance
|
Sort by Date
27 Jul 2009, 2:28 am
Today, when healthcare providers prescribe the cardiac drug Digoxin to a patient, [whether it will be as Lanoxin (GalaxoSmithKline) or as Digitek (Actavis Totowa)], those providers will usually monitor patient blood levels to determine the correct dosage on a case by case basis. [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram) – US:… [read post]
26 Jun 2009, 7:10 pm
Last year, a different generic drug company, Actavis Group, recalled its generic digoxin medication due to concerns that some of the tablets had been manufactured twice as thick as the company intended. [read post]
3 Jun 2009, 11:18 am
Reglan (metoclopramide) is prescribed for short-term treatment of gastrointestinal disorders.The Petition was opposed by several drug maker of metoclopramide including Teva Pharmaceuticals USA, Actavis Elizabeth, Barr Pharmaceuticals and Pliva. [read post]
28 May 2009, 10:12 pm
Request for Reglan lawsuit consolidation was opposed by the attorneys for companies involved in the litigation, including Wyeth, who manufactured the brand name Reglan products, and several manufacturers of generic versions, such as Baxter, Pliva, Barr, Duramed, Actavis, Teva and Scwarz Pharma. [read post]
11 May 2009, 5:00 am
.; Actavis, Inc.; and Actavis Elizabeth LLC in Pennsylvania state court for injuries she allegedly suffered from the long-term ingestion of Reglan (or metoclopramide) as prescribed by her physician. [read post]
8 May 2009, 11:16 am
Actavis Totowa LLC, 2009 WL 1082026 (N.D. [read post]
8 May 2009, 8:00 am
(Property intangible) US: Supreme Court rules 9-0 that CAFC has jurisdiction to review case remanded by district court to state court: Carlsbad Technology Inc v HIF Bio, Inc et al (Managing Intellectual Property) (Patently-O) US: Anticipation by a laundry list of prophetic DNA sequences: In re Gleave (Holman's Biotech IP Blog) US: Reverse payment settlements and biotechnology (Holman's Biotech IP Blog) US: Biogen seeks review and correction of patent term adjustment calculation in respect… [read post]
8 May 2009, 12:10 am
Actavis Totowa LLC, 2009 WL 1082026 (N.D. [read post]
24 Apr 2009, 9:25 am
The argument was that the generic makers did not develop the drug's warning label.The lawsuit was filed against Wyeth, which manufactured the drug metoclopramide under the brand name Reglan, and others including Teva Pharmaceuticals USA, Actavis Elizabeth, Barr Pharmaceuticals and Pliva.You can read the opinion here, in PDF format. [read post]
21 Apr 2009, 2:34 am
Not even a year has passed since the massive recall of Digitek pills by Bertek/Mylan and Actavis, yet cardiac patients are facing yet another scare. [read post]
31 Mar 2009, 12:16 pm
" Almost a year ago, in late April 2008, all digoxin pills manufactured by Actavis Totowa -- marketed under the Digitek brand name -- were recalled due to this so-called "double-dose" manufacturing problem. [read post]
27 Mar 2009, 8:00 am
; no skulduggery involved in pharma enquiry submission switch says EPO (IPKat) (IAM) India: Public sector IP and socially responsible licensing (Spicy IP) India: Pharma lobby wants a probe into delayed orders (Spicy IP) UK: Euro costs in UK litigation: Actavis UK Ltd v Novartis AG (PatLit) US: Two biosimilars bills introduced in the House: HR 1427, the Promoting Innovation and Access to Life Saving Medicine Act; and H.R. 1548, the Pathway to BioSimilars Act (California Biotech Law Blog)… [read post]
25 Mar 2009, 12:17 pm
As we have reported previously, here, during the past year there have been other cGMP violations leading to generic drug recalls by Actavis, ETHEX / KV Pharmaceutical, and Sandoz / Novartis. [read post]
13 Mar 2009, 2:00 am
(Patent Baristas) US: Schering merger includes legal headaches for Merck, including IP suits (Law360) US: Lessig and Eisen article ‘Is John Conyers Shilling for Special Interests’ concerning proposal to ban open access publishing requirement for taxpayer funded medical scientists (Huffington Post) (Lessig) (Lenz Blog) (Lessig) (Lenz Blog) (Michigan Messenger) (Lessig) US: McCain touts drug imports to lower US costs (Law360) US: Biotech and pharma provide little support in… [read post]
4 Mar 2009, 11:00 pm
(Spicy IP) Kenya enacts Biosafety Act 2/2009 regulating activities in GMOs, establishing National Biosafety Authority (Afro-IP) US: BIO meets the press: economic health of the biotech industry; follow-on biologics; patent reform (Patent Docs) (Patent Docs) (Intellectual Property Watch) US: Obama touts generic biologics to lower drug costs (Law360) US: Genentech announces victory in Cabilly re-examination (Patent Docs) US: Federal judge rejects Scruggs family’s bid to reconsider summary… [read post]
2 Mar 2009, 9:28 pm
In addition to Penwest and Endo agreeing to dismiss their suit with prejudice, Actavis has agreed to dismiss its counterclaims with... [read post]
20 Feb 2009, 1:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: GSK floats patent pool for neglected diseases (Spicy IP) (Intellectual Property Watch) (IAM) (guardian.co.uk) (IPKat) European Patent Office accepts traditional knowledge database from Indian government to help stop ‘biopiracy’ (Managing Intellectual Property) (Out-Law) (Intellectual Property Watch) General GSK… [read post]
6 Feb 2009, 5:00 am
Stem cell research under Obama (Ars Technica) US: Oxford Gene Technology settles legal action with Bioarray Solutions over patents covering use of microassays for detection of DNA sequence variations (Patent Docs) US: BPAI affirms rejection of claims to an isolated protein over prior art disclosing nucleic acid encoding the protein: Ex parte Chuang (not precedential) (Patent Docs) (Post-Grant) US: Supreme petitioned to grant certiorari in two cases important to biotech patenting: In re Bilski and… [read post]
29 Jan 2009, 12:46 pm
Some recent topics include the peanut butter recall and Digitek manufacturer Actavis' plant shutdown. [read post]
